Industry Overview
The global house dust mite allergy treatment market was valued at $2.8bn in 2024 and is projected to reach $8.75bn by 2033, growing at 13.5% CAGR. Growth is driven by rising indoor allergen exposure, preventative healthcare trends, and increasing demand for bedding protection and indoor hygiene solutions. North America remains a leading region for adoption.
Business Description
Acquisition of the exclusive Canadian Master Licence for CleanMyBed, delivering medical-grade, dry, chemical-free mattress sanitisation. The model includes two aligned brands: CleanMyBed (residential) and Peace of Sleep (hospitality certification). Operations are powered by Sentinel, a proprietary business management platform integrating bookings, CRM, invoicing, certification, territory analytics, reporting and team management. Partners launch with a fully built system, not a start-up concept.
Financial Summary
Financial Summary:
Master Licence Fee: $760,000 CAD
Projected system revenue:
$456,000 CAD per month
$5,472,000 CAD per year
Projected Master earnings:
$71,140 CAD per month
$853,680 CAD per year
Sub-licence price: $27,500 CAD
38 territory sales generate $888,250 CAD in one-time income.
Target payback: 24 months
Investment Rationale
Exclusive national rights, dual revenue streams, conservative base modelling, scalable sub-licensing structure and proprietary technology infrastructure within a rapidly expanding indoor health category.
Customer Overview
Health-conscious households and allergy-aware consumers, alongside hotels and accommodation providers requiring certified mattress hygiene standards.
Transaction Information
Acquisition of exclusive Canadian Master Licence with full national operating and sub-licensing rights.
To register interest you will need to complete our Buyer Verification Process.
